Treatment for Overactive Bladder (EVANESCE-OAB Trial)

N/A

Waitlist Available

Research Sponsored by FemPulse Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 11 days in total

The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 11 days in total

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 11 days in total

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 11 days in total for reporting.

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

All device- and procedure-related adverse events will be collected and tabulated

Incontinence Impact Questionnaire - Short Form

OAB Symptom Score

+5 more

2Treatment groups

Experimental Treatment

Placebo Group

Group I: TreatmentExperimental Treatment1 Intervention

FemPulse System at one device setting

Group II: ControlPlacebo Group1 Intervention

FemPulse System at a different device setting

Do I qualify?Apply below to find out

FemPulse CorporationLead Sponsor

3 Previous Clinical Trials

37 Total Patients Enrolled

~3 spots leftby Oct 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.